Dimitrios Giannakopoulos
| Dimitrios Giannakopoulos Δημήτρης Γιαννακόπουλος |
|
|---|---|
| Born |
Dimitrios Giannakopoulos 1 January 1974 Athens, Greece |
| Residence | Athens, Attica, Greece |
| Nationality |
 Greek |
| Occupation | Owner of DPG Group Vice President of Vianex Owner of Panathinaikos B.C. Owner of Sparta F.C. |
| Parent(s) | Pavlos Giannakopoulos (father) |
| Relatives | Thanasis Giannakopoulos (uncle) |
| Website | http://www.vianex.gr/ |
Dimitrios P. Giannakopoulos (alternate spellings: Dimitris Giannacopoulos) (Greek: Δημήτρης Π. Γιαννακόπουλος) is a Greek businessman, vice-president of the Board of Directors and Deputy CEO of VIANEX and major shareholder of Greek Basket League club Panathinaikos Athens.
Dimitris Giannakopoulos is Pavlos Giannakopoulos’ son and Thanasis Giannakopoulos’s nephew, owners of VIANEX, the largest Greek pharmaceutical company today. The family’s engagement in the pharmaceutical sector began with his grandfather, Dimitris Giannakopoulos from Sellasia in Laconia, who in 1924 opened a pharmacy in the centre of Athens.
In 1971, Pavlos Giannakopoulos founded VIANEX. In 2012, despite the Greek financial crisis, the company announced net sales of up to €240,200,000. He is now the heir of the dynasty built by his father and his uncles, including both VIANEX and Panathinaikos B.C., marking the emergence of the new generation in particularly difficult times. In 2004, he was made first vice-president at VIANEX, while since January 2012, he has also assumed the office of Deputy CEO.
He is married to Ioanna Marosouli, with whom he has two children.
Dimitris Giannakopoulos took on the family business from his father, Pavlos, in January 2012, when he became Deputy CEO, additionally to being vice-president of the Board of Directors of VIANEX.
The company entered the new era under Dimitris Giannakopoulos' management, that was connected with the increase of openness and the conclusion of important deals, either new ones or renewals of old ones. In July 2013, on the occasion of the announcement of the cooperation between VIANEX and Eli Lilly, for the production of the inject-able antibiotic Vancomycin on the premises of VIANEX in China, and the export of 100% of the production to the Chinese market, Pavlos Giannakopoulos stated: "I handed over to him the reigns of the largest Greek pharmaceutical company in the country, and I am convinced he will someday turn it into the largest pharmaceutical company even abroad". VIANEX's goals include expansion to other foreign markets as well, such as South Korea, Vietnam, Japan, and Arabic countries.
...
Wikipedia